T1	Treatment 11 21	perampanel
T2	Treatment 159 169	perampanel
T3	Treatment 587 635	to once-daily perampanel 8 mg, 12 mg, or placebo
T4	Treatment 707 809	phase: 6-week titration (2 mg/week increments to target dose) followed by a 13-week maintenance period
T5	Treatment 1168 1194	for placebo and perampanel
T6	Treatment 1395 1418	for placebo, perampanel
T7	Treatment 1425 1439	and perampanel
T8	Treatment 1800 1821	adjunctive perampanel
T9	Treatment 2101 2122	adjunctive perampanel
